Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Shuaishuai CAO"'
Autor:
Fengze Wang, Jiao Wen, Shuaishuai Cao, Xinjie Yang, Zihui Yang, Huan Li, Haifeng Meng, Florian M. Thieringer, Jianhua Wei
Publikováno v:
BMC Oral Health, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Few models about the personalized prognosis evaluation of buccal mucosa cancer (BMC) patients were reported. We aimed to establish predictive models to forecast the prognosis of BMC patients. Methods The complete clinicopathologic
Externí odkaz:
https://doaj.org/article/96359b4e3463465286f62c8794696b33
Autor:
Lu Zhang, Lizhen Wang, Shuaishuai Cao, Huanhuan Lv, Jingjing Huang, Guixi Zhang, Kaissar Tabynov, Qin Zhao, En-Min Zhou
Publikováno v:
Veterinary Research, Vol 52, Iss 1, Pp 1-14 (2021)
Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) is a highly contagious virus that has led to enormous economic loss worldwide because of ineffective prevention and treatment. In view of their minimized size, high target specifici
Externí odkaz:
https://doaj.org/article/f8a25a84bf2a4ec88ae55d7c33940b0b
Autor:
Zhichen Sun, Zhenhua Ren, Kaiting Yang, Zhida Liu, Shuaishuai Cao, Sisi Deng, Lily Xu, Yong Liang, Jingya Guo, Yingjie Bian, Hairong Xu, Jiyun Shi, Fan Wang, Yang-Xin Fu, Hua Peng
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Interleukin-2 (IL-2) based cancer therapy is limited by severe toxicity and strong Treg amplification at the therapeutic dosage. Here, the authors develop a recombinant IL-2 immunocytokine which is comprised of a tumor-targeting antibody fused to a s
Externí odkaz:
https://doaj.org/article/d9466bada18644f1bed8cb45aa2a8e1a
Publikováno v:
Energies, Vol 13, Iss 23, p 6293 (2020)
Energy storage technology plays a significant role in the pursuit of the high-quality development of the electricity market. Many regions in China have issued policies and regulations of different intensities for promoting the popularization of the e
Externí odkaz:
https://doaj.org/article/7b2e32b741e2492ba6f071951bc7adec
Autor:
Zhichen Sun, Zhenhua Ren, Kaiting Yang, Zhida Liu, Shuaishuai Cao, Sisi Deng, Lily Xu, Yong Liang, Jingya Guo, Yingjie Bian, Hairong Xu, Jiyun Shi, Fan Wang, Yang-Xin Fu, Hua Peng
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/eb1092bb98ea40d8a68e6eb6d71dcefc
Publikováno v:
Energy for Sustainable Development. 71:378-388
Publikováno v:
Xibei Gongye Daxue Xuebao/Journal of Northwestern Polytechnical University. 40:189-198
In order to control the forming surface quality of signal crystal turbine blade tenon teeth in the creep feed grinding, the influence of the creep feed grinding parameters on the grinding surface integrity of DD5 nickel-based single crystal superallo
Autor:
Hongwei Wang, Lei Cheng, Shuaishuai Cao, Mingzhi Yu, Florian M. Thieringer, Dong Zhang, Yi Wan, Bing Ren, Da-Wang Zhao, Yuan-Hua Sang, Chao Liu, Xiao Zhang
Publikováno v:
Bone & Joint Research
Bone & Joint Research, Vol 10, Iss 7, Pp 411-424 (2021)
Bone & Joint Research, Vol 10, Iss 7, Pp 411-424 (2021)
Aims The use of 3D-printed titanium implant (DT) can effectively guide bone regeneration. DT triggers a continuous host immune reaction, including macrophage type 1 polarization, that resists osseointegration. Interleukin 4 (IL4) is a specific cytoki
Autor:
Bilal Msallem, Michaela Maintz, Florian S. Halbeisen, Simon Meyer, Guido R. Sigron, Neha Sharma, Shuaishuai Cao, Florian M. Thieringer
Publikováno v:
Materials; Volume 15; Issue 5; Pages: 1970
Cranioplasty with freehand-molded polymethylmethacrylate implants is based on decades of experience and is still frequently used in clinical practice. However, data confirming the fracture toughness and standard biomechanical tests are rare. This stu
Autor:
Diyuan Xue, Benjamin Moon, Jing Liao, Jingya Guo, Zhuangzhi Zou, Yanfei Han, Shuaishuai Cao, Yang Wang, Yang-Xin Fu, Hua Peng
Publikováno v:
Sci Immunol
It is a challenge to effectively reactivate preexisting tumor-infiltrating lymphocytes (TILs) without causing severe toxicity. IL-12 can potently activate lymphocytes, but its clinical use is limited by its short half-life and dose-related toxicity.